Carderock Capital Management’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Sell
213,150
-13,758
-6% -$992K 4.12% 3
2026
Q1
$14.3M Sell
226,908
-20,642
-8% -$1.45M 3.54% 3
2025
Q4
$16.7M Sell
247,550
-20,436
-8% -$1.37M 4.05% 3
2025
Q3
$16.6M Sell
267,986
-6,576
-2% -$361K 4.03% 1
2025
Q2
$13.6M Sell
274,562
-37,568
-12% -$1.54M 3.47% 1
2025
Q1
$10.2M Sell
312,130
-19,800
-6% -$675K 2.71% 6
2024
Q4
$11.5M Sell
331,930
-12,306
-4% -$431K 2.89% 5
2024
Q3
$11.2M Sell
344,236
-882
-0.3% -$28.6K 2.65% 7
2024
Q2
$11.6M Buy
345,118
+6,518
+2% +$206K 3.04% 4
2024
Q1
$9.76M Sell
338,600
-15,348
-4% -$402K 2.74% 9
2023
Q4
$8.77M Buy
353,948
+21,308
+6% +$471K 2.42% 12
2023
Q3
$6.98M Sell
332,640
-5,144
-2% -$111K 2.34% 14
2023
Q2
$7.17M Buy
337,784
+15,372
+5% +$299K 2.22% 17
2023
Q1
$6.59M Sell
322,412
-6,148
-2% -$121K 2.3% 11
2022
Q4
$6.25M Sell
328,560
-1,884
-0.6% -$35.6K 2.59% 9
2022
Q3
$5.53M Sell
330,444
-8,616
-3% -$156K 2.82% 10
2022
Q2
$5.46M Buy
339,060
+7,260
+2% +$126K 2.28% 12
2022
Q1
$6.25M Sell
331,800
-137,480
-29% -$2.66M 2.02% 14
2021
Q4
$10.3M Sell
469,280
-6,748
-1% -$137K 2.46% 11
2021
Q3
$8.71M Sell
476,028
-3,128
-0.7% -$57.4K 2.46% 12
2021
Q2
$8.2M Buy
479,156
+412
+0.1% +$6.95K 2.25% 13
2021
Q1
$7.9M Sell
478,744
-3,800
-0.8% -$61.7K 2.36% 11
2020
Q4
$7.89M Buy
482,544
+4,944
+1% +$76K 2.38% 13
2020
Q3
$6.46M Buy
477,600
+7,808
+2% +$103K 2.18% 14
2020
Q2
$5.63M Sell
469,792
-144
-0% -$1.61K 2.07% 17
2020
Q1
$4.28M Sell
469,936
-61,592
-12% -$734K 1.96% 24
2019
Q4
$7.19M Buy
531,528
+5,808
+1% +$74.1K 2.41% 7
2019
Q3
$6.34M Buy
525,720
+1,616
+0.3% +$18.6K 2.33% 10
2019
Q2
$6.29M Sell
524,104
-344
-0.1% -$4.14K 2.37% 9
2019
Q1
$6.19M Buy
524,448
+184
+0% +$2.06K 2.53% 7
2018
Q4
$5.31M Sell
524,264
-34,960
-6% -$375K 2.74% 8
2018
Q3
$6.57M Sell
559,224
-112
-0% -$1.3K 2.59% 9
2018
Q2
$6.09M Sell
559,336
-9,032
-2% -$98.3K 2.63% 6
2018
Q1
$6.12M Sell
568,368
-11,992
-2% -$135K 2.7% 6
2017
Q4
$6.37M Sell
580,360
-17,696
-3% -$195K 2.81% 5
2017
Q3
$6.33M Sell
598,056
-1,752
-0.3% -$17.2K 2.85% 5
2017
Q2
$5.54M Sell
599,808
-1,368
-0.2% -$12.5K 2.5% 8
2017
Q1
$5.35M Sell
601,176
-32,648
-5% -$282K 2.47% 7
2016
Q4
$5.32M Sell
633,824
-7,640
-1% -$63.6K 2.66% 7
2016
Q3
$5.21M Buy
641,464
+37,984
+6% +$289K 2.61% 6
2016
Q2
$4.33M Sell
603,480
-17,816
-3% -$128K 2.29% 18
2016
Q1
$4.49M Sell
621,296
-5,016
-0.8% -$32.6K 2.3% 18
2015
Q4
$4.09M Buy
626,312
+4,360
+0.7% +$29.1K 2.13% 22
2015
Q3
$3.96M Buy
621,952
+680
+0.1% +$4.57K 2.21% 20
2015
Q2
$4.5M Sell
621,272
-320
-0.1% -$2.3K 2.26% 16
2015
Q1
$4.58M Sell
621,592
-29,616
-5% -$207K 2.22% 19
2014
Q4
$4.38M Buy
651,208
+6,328
+1% +$40.5K 2.16% 19
2014
Q3
$4.03M Sell
644,880
-9,552
-1% -$59.9K 2.07% 19
2014
Q2
$3.94M Sell
654,432
-4,016
-0.6% -$23.9K 2.06% 18
2014
Q1
$3.77M Sell
658,448
-224
-0% -$1.25K 1.92% 19
2013
Q4
$3.67M Sell
658,672
-544
-0.1% -$2.81K 1.92% 20
2013
Q3
$3.19M Buy
659,216
+2,016
+0.3% +$9.84K 1.85% 19
2013
Q2
$3.2M Buy
+657,200
New +$3.15M 1.89% 19

Other funds holding APH

Carderock Capital Management's APH Position: Q2 2026 in Review

Carderock Capital Management reduced its Amphenol (APH) stake by 6.1% in Q2 2026, selling an estimated $992K and leaving 213,150 shares worth $18.8M. The position accounts for 4.12% of the portfolio, ranked #3.

Carderock Capital Management first reported a position in APH in Q2 2013 and has held it in 53 quarters since. 2,334 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Carderock Capital Management held 213,150 shares of Amphenol worth $18.8M as of Q2 2026.
  • Carderock Capital Management sold 13,758 Amphenol shares in Q2 2026, an estimated $992K.
  • Amphenol made up 4.12% of Carderock Capital Management's portfolio in Q2 2026, its #3 holding.
  • Carderock Capital Management first reported a position in Amphenol in Q2 2013 and has held it in 53 quarters since.
  • 2,334 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.